Increasing the Safety of Biological Liquid Waste Disposal
INTEGRA has launched new single-use waste collection bottles for its VACUSIP benchtop aspiration system – a compact, portable solution for safe and convenient disposal of small volumes of biological liquid waste.
The introduction of new disposable bottles allows VACUSIP users to go one step further in terms of operational safety and reducing the cost of handling/disposal of biohazardous substances. Made of heavy duty polypropylene, the new single-use collection bottle is shatterproof and vacuum resistant, eliminating risks of breakage and contamination by the biological agents during manipulation.
Benefiting from a compact design enables all manipulation, aspiration and liquid waste collection steps using a VACUSIP to be done inside a biosafety cabinet, reducing risks of human and environmental contamination by manipulated biohazard agents. A wide range of adapters are available enabling easy aspiration of liquid from almost any labware including small centrifuges tubes, microplates or flasks. When full, the collection bottle is simply disconnected from the VACUSIP system and securely sealed with the supplied lid.
After decontamination of the bottle surface, the liquid waste can be simply and safely transferred to a licensed company for correct destruction of the biohazardous substances. Using the new VACUSIP single-use waste collection bottles therefore not only reduces biohazard handling risks but also eliminates the need, and considerable cost, of maintaining an in-house waste disposal facility.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance